Vimarsana
Biggest News Aggregation in the World

Page 10 - Nasdaq Edit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Edit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Edit Today - Breaking & Trending Today

Editas Medicine (NASDAQ:EDIT) Releases Earnings Results, Beats Estimates By $0.08 EPS - Vimarsana News

Editas Medicine (NASDAQ:EDIT) Releases Earnings Results, Beats Estimates By $0.08 EPS

Editas Medicine (NASDAQ:EDIT – Get Rating) released its earnings results on Friday. The company reported ($0.71) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.79) by $0.08, Briefing.com reports. The firm had revenue of $9.90 million for the quarter, compared to analyst estimates of $3.29 million. Editas Medicine had a negative […]

Editas Medicine, Inc. (NASDAQ:EDIT) Receives $15.33 Consensus Target Price from Analysts - Vimarsana News

Editas Medicine, Inc. (NASDAQ:EDIT) Receives $15.33 Consensus Target Price from Analysts

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) has been given a consensus recommendation of “Hold” by the sixteen brokerages that are currently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and four have issued a buy recommendation on the company. The […]

Editas Medicine (NASDAQ:EDIT) Shares Up 8.4% - Vimarsana News

Editas Medicine (NASDAQ:EDIT) Shares Up 8.4%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) shares shot up 8.4% during trading on Monday . The stock traded as high as $8.32 and last traded at $8.23. 443,238 shares were traded during trading, a decline of 75% from the average session volume of 1,793,685 shares. The stock had previously closed at $7.59. Wall Street […]

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Hold" from Brokerages - Vimarsana News

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) have been given an average rating of “Hold” by the sixteen ratings firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to […]

Source: wkrb13.com
Editas Medicine (NASDAQ:EDIT) Shares Down 4.3% - Vimarsana News

Editas Medicine (NASDAQ:EDIT) Shares Down 4.3%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) fell 4.3% during trading on Wednesday . The company traded as low as $7.70 and last traded at $7.70. 317,125 shares traded hands during trading, a decline of 82% from the average session volume of 1,730,446 shares. The stock had previously closed at $8.05. Analyst Upgrades and Downgrades […]

Source: wkrb13.com